{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:26:21Z","timestamp":1789244781471,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T00:00:00Z","timestamp":1673654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T00:00:00Z","timestamp":1673654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>An association with aortic aneurysm has been reported among patients with atrial fibrillation (AF). The aims of this study were to investigate the prevalence of thoracic aorta aneurysm (TAA) among patients with AF and to assess whether the co-presence of TAA is associated with a higher risk of adverse clinical outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods and results<\/jats:title>\n                <jats:p>Using TriNetX, a global federated health research network of anonymised electronic medical records, all adult patients with AF, were categorised into two groups based on the presence of AF and TAA or AF alone. Between 1 January 2017 and 1 January 2019, 874,212 people aged\u2009\u2265\u200918\u00a0years with AF were identified. Of these 17,806 (2.04%) had a TAA. After propensity score matching (PSM), 17,805 patients were included in each of the two cohorts. During the 3\u00a0years of follow-up, 3079 (17.3%) AF patients with TAA and 2772 (15.6%) patients with AF alone, developed an ischemic stroke or transient ischemic attack (TIA). The risk of ischemic stroke\/TIA was significantly higher in patients with AF and TAA (HR 1.09, 95% CI 1.04\u20131.15; log-rank <jats:italic>p<\/jats:italic> value\u2009&lt;\u20090.001)<\/jats:p>\n                <jats:p>The risk of major bleeding was higher in patients with AF and TAA (OR 1.07, 95% CI 1.01\u20131.14), but not significant in time-dependent analysis (HR 1.04, 95% CI 0.98\u20131.10; log-rank <jats:italic>p<\/jats:italic> value\u2009=\u20090.187),<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This retrospective analysis reports a clinical concomitance of the two medical conditions, and shows in a PSM analysis an increased risk of ischemic events in patients affected by TAA and AF compared to AF alone.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11739-022-03184-6","type":"journal-article","created":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T14:03:06Z","timestamp":1673704986000},"page":"423-428","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Thoracic aortic aneurysm and atrial fibrillation: clinical associations with the risk of stroke from a global federated health network analysis"],"prefix":"10.1007","volume":"18","author":[{"given":"Riccardo","family":"Proietti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Miguel","family":"Rivera-Caravaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie Lucy","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin James Roy","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"L\u00f3pez-G\u00e1lvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Fairbairn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Madine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riaz","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Underhill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Field","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Yoke Hong","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,14]]},"reference":[{"issue":"3","key":"3184_CR1","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S0022-5223(97)70360-X","volume":"113","author":"MA Coady","year":"1997","unstructured":"Coady MA, Rizzo JA, Hammond GL, Mandapati D, Darr U, Kopf GS et al (1997) What is the appropriate size criterion for resection of thoracic aortic aneurysms? J Thorac Cardiovasc Surg 113(3):476\u2013491 (discussion 89-91)","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"7","key":"3184_CR2","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1111\/jocs.15548","volume":"36","author":"A Lopuszko","year":"2021","unstructured":"Lopuszko A, Patrick Tan SZC, Munir W, Bashir M (2021) Aortic aneurysm disease-Make room for chronobiology. J Card Surg 36(7):2496\u20132501","journal-title":"J Card Surg"},{"issue":"5","key":"3184_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000493692","volume":"55","author":"CC Hsu","year":"2018","unstructured":"Hsu CC, Chien WC, Wang JC, Chung CH, Liao WI, Lin WS et al (2018) Association between Atrial Fibrillation and Aortic Aneurysms: a population-based cohort study. J Vasc Res 55(5):299\u2013307","journal-title":"J Vasc Res"},{"key":"3184_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.amjcard.2020.10.059","volume":"140","author":"J Ramchand","year":"2021","unstructured":"Ramchand J, Bansal A, Saeedan MB, Wang TKM, Agarwal R, Kanj M et al (2021) Incidental thoracic aortic dilation on chest computed tomography in patients with atrial fibrillation. Am J Cardiol 140:78\u201382","journal-title":"Am J Cardiol"},{"issue":"1","key":"3184_CR5","first-page":"20","volume":"122","author":"TF Chao","year":"2021","unstructured":"Chao TF, Joung B, Takahashi Y, Lim TW, Choi EK, Chan YH et al (2021) Focused update consensus guidelines of the Asia Pacific heart rhythm society on stroke prevention in atrial fibrillation: executive summary. Thromb Haemost 122(1):20\u201347","journal-title":"Thromb Haemost"},{"issue":"5","key":"3184_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C et al (2021) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42(5):373\u2013498","journal-title":"Eur Heart J"},{"issue":"2","key":"3184_CR7","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/europace\/euaa358","volume":"23","author":"J Zhang","year":"2021","unstructured":"Zhang J, Lenarczyk R, Marin F, Malaczynska-Rajpold K, Kosiuk J, Doehner W et al (2021) The interpretation of CHA2DS2-VASc score components in clinical practice: a joint survey by the European Heart Rhythm Association (EHRA) Scientific Initiatives Committee, the EHRA Young Electrophysiologists, the association of cardiovascular nursing and allied professionals, and the European Society of Cardiology Council on Stroke. Europace 23(2):314\u2013322","journal-title":"Europace"},{"issue":"15","key":"3184_CR8","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1001\/jama.2015.13480","volume":"314","author":"JS Haukoos","year":"2015","unstructured":"Haukoos JS, Lewis RJ (2015) The propensity score. JAMA 314(15):1637\u20131638","journal-title":"JAMA"},{"issue":"12","key":"3184_CR9","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/j.amjcard.2014.09.025","volume":"114","author":"L Yankelson","year":"2014","unstructured":"Yankelson L, Steinvil A, Gershovitz L, Leshem-Rubinow E, Furer A, Viskin S et al (2014) Atrial fibrillation, stroke, and mortality rates after transcatheter aortic valve implantation. Am J Cardiol 114(12):1861\u20131866","journal-title":"Am J Cardiol"},{"issue":"11","key":"3184_CR10","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1093\/europace\/eus087","volume":"14","author":"RC Davis","year":"2012","unstructured":"Davis RC, Hobbs FD, Kenkre JE, Roalfe AK, Iles R, Lip GY et al (2012) Prevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES study. Europace 14(11):1553\u20131559","journal-title":"Europace"},{"issue":"3\u20134","key":"3184_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3121\/cmr.2009.866","volume":"8","author":"DR Kumar","year":"2010","unstructured":"Kumar DR, Hanlin E, Glurich I, Mazza JJ, Yale SH (2010) Virchow\u2019s contribution to the understanding of thrombosis and cellular biology. Clin Med Res 8(3\u20134):168\u2013172","journal-title":"Clin Med Res"},{"issue":"7","key":"3184_CR12","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1161\/STROKEAHA.109.548313","volume":"40","author":"C Russo","year":"2009","unstructured":"Russo C, Jin Z, Rundek T, Homma S, Sacco RL, Di Tullio MR (2009) Atherosclerotic disease of the proximal aorta and the risk of vascular events in a population-based cohort: the Aortic Plaques and Risk of Ischemic Stroke (APRIS) study. Stroke 40(7):2313\u20132318","journal-title":"Stroke"},{"issue":"9","key":"3184_CR13","doi-asserted-by":"publisher","first-page":"862","DOI":"10.4065\/74.9.862","volume":"74","author":"I Meissner","year":"1999","unstructured":"Meissner I, Whisnant JP, Khandheria BK, Spittell PC, O\u2019Fallon WM, Pascoe RD et al (1999) Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study Stroke. Prevention: assessment of risk in a Community. Mayo Clin Proc 74(9):862\u2013869","journal-title":"Mayo Clin Proc"},{"issue":"17","key":"3184_CR14","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1161\/CIRCULATIONAHA.108.811935","volume":"119","author":"MR Di Tullio","year":"2009","unstructured":"Di Tullio MR, Russo C, Jin Z, Sacco RL, Mohr JP, Homma S (2009) Aortic arch plaques and risk of recurrent stroke and death. Circulation 119(17):2376\u20132382","journal-title":"Circulation"},{"issue":"1","key":"3184_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1161\/CIRCULATIONAHA.105.593418","volume":"114","author":"I Kronzon","year":"2006","unstructured":"Kronzon I, Tunick PA (2006) Aortic atherosclerotic disease and stroke. Circulation 114(1):63\u201375","journal-title":"Circulation"},{"issue":"11","key":"3184_CR16","doi-asserted-by":"publisher","first-page":"997","DOI":"10.5551\/jat.48181","volume":"26","author":"K Kojima","year":"2019","unstructured":"Kojima K, Kimura S, Hayasaka K, Mizusawa M, Misawa T, Yamakami Y et al (2019) Aortic plaque distribution, and association between aortic plaque and atherosclerotic risk factors: an aortic angioscopy study. J Atheroscler Thromb 26(11):997\u20131006","journal-title":"J Atheroscler Thromb"},{"issue":"4","key":"3184_CR17","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1093\/cvr\/cvac016","volume":"118","author":"R Proietti","year":"2022","unstructured":"Proietti R, Lip GYH, Akhtar R, Field M (2022) Thoracic aortic aneurysms and atrial fibrillation: commonality in pathophysiological pathways. Cardiovasc Res 118(4):e32\u2013e35","journal-title":"Cardiovasc Res"},{"key":"3184_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105418","volume":"165","author":"D Pastori","year":"2021","unstructured":"Pastori D, Baratta F, Di Rocco A, Farcomeni A, Del Ben M, Angelico F et al (2021) Statin use and mortality in atrial fibrillation: a systematic review and meta-analysis of 100,287 patients. Pharmacol Res 165:105418","journal-title":"Pharmacol Res"},{"issue":"8","key":"3184_CR19","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.amjcard.2013.05.081","volume":"112","author":"LH Stein","year":"2013","unstructured":"Stein LH, Berger J, Tranquilli M, Elefteraides JA (2013) Effect of statin drugs on thoracic aortic aneurysms. Am J Cardiol 112(8):1240\u20131245","journal-title":"Am J Cardiol"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-022-03184-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-022-03184-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-022-03184-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T13:53:57Z","timestamp":1678888437000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-022-03184-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,14]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["3184"],"URL":"https:\/\/doi.org\/10.1007\/s11739-022-03184-6","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,14]]},"assertion":[{"value":"7 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JMRC: consultant for Idorsia Pharmaceuticals LTD. GYHL: consultant and speaker for BMS\/Pfizer, Boehringer Ingelheim and Daiichi-Sankyo. No fees are received personally. There is nothing to disclose for other authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}